Group items tagged

Mainstream medical treatment of cancer revolves around surgery, chemotherapy, and radiation therapy, used either alone or in combination (Isobe T et al 2005; Ostoros G et al 2005). Chemotherapy and radiation therapy cannot discriminate between cancer cells and healthy cells; thus, they damage both types of cells and cause serious and often debilitating side effects, frequently forcing patients to abandon treatment (Ettinger DS 2005; Giraud P et al 2004; Munden RF et al 2005). Therefore, it is not surprising that many cancer patients now opt to complement conventional treatments with alternative therapies that may not only temper the adverse side effects of conventional cancer therapy, but also improve its effectiveness via independent anti-cancer effects.

Lerner, Michael, 1943 - Choices in healing : integrating the best of conventional and complementary approaches to cancer / Michael Lerner. p. cm. Includes bibliographical references and index. ISBN 0-262-12180-8 1. Cancer--Treatment. 2. Cancer--Alternative treatment. 3. Cancer--Popular works. I. Title. RC270.8.L47 1994 616.99é406--dc20 93-39913 CIP

"University of Michigan Integrative Medicine, an interdisciplinary program, is committed to the thoughtful and compassionate integration of complementary therapies and conventional medicine through the activities of research, education, clinical services and community partnerships. As a healing-oriented approach to medical care, integrative medicine takes into account the whole person (body, mind, spirit and emotion), including all aspects of lifestyle. The vision, mission and values of the University of Michigan Integrative Medicine (UMIM) program reflect our belief that patients and our community are best served when all available therapies are considered in concert with an approach that recognizes the intrinsic wholeness of each individual. It also reflects our belief that the best medicine is practiced in collaboration with a wide variety of healthcare professionals and with our patients. Our vision: To facilitate healing and wellness of mind, body, heart and spirit through clinical services, research and education. Our mission: To provide responsible leadership in the integration of complementary, alternative and conventional medicine. Our values: To live and work in balance with the community, the environment and each other. To touch beyond our reach and see beyond our vision."

"Not everyone has access to pastured eggs. "Omega-3 eggs" come from hens fed an omega-3 enriched diet*. Not only do they have a much higher omega-3 content than conventional eggs, they also contain less AA. One study found that omega-3 eggs contain 39% less AA than conventional and organic eggs. Omega-3 eggs were also rich in short- and long-chain omega-3 fats. Omega-3 eggs are certainly not nutritionally equivalent to pastured eggs, but they're a step in the right direction. "

Cimetidine - A Common Heartburn Remedy Complements Conventional Cancer Therapy By Cynthia Haines, MD LE Magazine May 2007

Roskamp Institute recently made three presentations, thirteen posters and a press conference at the Society for Neuroscience 2012 convention in New Orleans, the largest annual neurology related conference in the world.

"Cancer lies dormant in all of us," he wrote in his new book, "Anticancer: A New Way of Life" (Viking, $25.95). "But our bodies are also equipped with a number of mechanisms that detect and keep such (defective) cells in check." Cancer rears its ugly head when things get out of balance, Servan-Schreiber said in an interview. And that can happen if the bad guys that promote the growth of cancer cells (tobacco, excessive alcohol, excessive sugar, hydrogenated fats, environmental pollutants) outnumber the good guys that support our natural defenses (cancer-fighting phytochemicals found in fruits, vegetables, herbs and teas; physical activity; and stress management techniques). But conventional treatment, while indispensable, focuses on a single target: destroying cancer cells. Doctors rarely address the other side: teaching patients how to fortify themselves using nutrition, exercise and stress-management techniques to create an inhospitable environment for cancer.

Ergothioneine is a naturally-occurring amino acid and is a thiourea derivative of histidine, containing a sulfur atom in the imidazole ring. This compound is made in rather few organisms, notably Actinobacteria and filamentous fungi.[1] Ergothioneine was discovered in 1909 and named after the ergot fungus from which it was first purified, with its structure being determined later, in 1911.[2] This amino acid has antioxidant properties, but its chemistry differs from conventional sulfur-containing antioxidants such as glutathione or lipoic acid. Although ergothioneine cannot be made in human cells, it is present in some tissues at high levels as it is absorbed from the diet.[3] In humans ergothioneine is taken up from the gut and concentrated in the tissues by a specific transporter called the novel organic cation transporter. However, even today, one hundred years after its discovery, precisely what ergothioneine does in the human body remains a mystery

SSeason of diagnosis is a prognostic factor in Hodgkin's lymphoma: a possible role of sun-induced vitamin D. Porojnicu AC, Robsahm TE, Ree AH, Moan J. Br J Cancer. 2005 Sep 5;93(5):571-4. PMID: 16136030 doi:10.1038/sj.bjc.6602722 Epidemiological data for this period indicate that season of diagnosis is a strong prognostic factor for Hodgkin's lymphoma, with approximately 20% lower case fatality for patients diagnosed during autumn vs winter diagnosis (RR = 0.783, 95% CI,-0.62 to 0.99; P = 0.041). Notably, the improved autumnal survival rate was higher than 60% (RR = 0.364, 95% CI, -0.15 to 0.87; P = 0.025) for patients younger than 30 years. This finding may be related to higher endogenous levels of vitamin D in autumn, with a favourable influence on the conventional therapy. In conclusion, we have found that the prognosis of Hodgkin's lymphoma is significantly correlated with the season of diagnosis, particularly for patients younger than 30 years. This seasonal effect is presumably due to the vitamin D3 synthesis in skin during sun exposure. The present findings should encourage further investigations of the possible adjuvant role of vitamin D derivatives in cancer therapy

Conclusion A low-carbohydrate plant-based diet has lipid-lowering advantages over a high-carbohydrate, low-fat weight-loss diet in improving heart disease risk factors not seen with conventional low-fat diets with animal products. The Effect of a Plant-Based Low-Carbohydrate ("Eco-Atkins") Diet on Body Weight and Blood Lipid Concentrations in Hyperlipidemic Subjects David J. A. Jenkins; Julia M. W. Wong; Cyril W. C. Kendall; Amin Esfahani; Vivian W. Y. Ng; Tracy C. K. Leong; Dorothea A. Faulkner; Ed Vidgen; Kathryn A. Greaves; Gregory Paul; William Singer Arch Intern Med. 2009;169(11):1046-1054. DOI: 10.1001/archinternmed.2009.115

The Standing Committee of European Doctors (CPME) is preparing a vitamin D policy paper it hopes can influence European national associations considering vitamin D medical recommendations. PA International Foundation is hosting an event on the topic in Bruges, Belgium, on October 6, its 14th workshop to be held on the matter. The CPME draft paper will be presented at the convention attended by doctors, scientists, patient groups, media representatives and politicians.

Note: If you or your loved one has cancer, do not avoid, delay, or abandon conventional treatment due to anything you may see here. Cancer treatment has made great advances since 1990. Most alternatives have little to no value. Nothing you see here has been validated by completed human trials.

Beta Glucan is primarily cultured extract of Baker's Yeast cell wall. It is used as an immunostimulant.  Beta glucans are sugar molecules (polysaccharides). They are found bound together as a sugar/protein complex.  Certain plants and microorganisms are naturally high in this polysaccharide compound.  The richest concentrated source is baker's yeast cell walls. (Because there is basically no yeast left in the products and they have low protein levels, it is considered hypoallergenic.) It is present in lesser amounts in mushroom extracts and Lentinen, Barley, Oat, etc. Sodium alginate is also an excellent source, but the high sodium content is a major drawback in the processing for supplemental use. An expensive research extract called Zymosan™ has been used for doing research for over 45 years. Much of the research has been in combining it with conventional approaches, such as chemotherapy, but it has been found to work well on its own.

"Largest-ever meta-analysis finds CRP is unlikely to be causal for CVD December 21, 2009 | Lisa Nainggolan Cambridge, UK - In the largest and most comprehensive meta-analysis to date looking at C-reactive-protein (CRP) levels and risk of coronary heart disease (CHD) and stroke, British researchers conclude that CRP is unlikely to be a causal factor for cardiovascular disease [1]. Although CRP concentration was linearly associated with CHD, stroke, and vascular mortality, as well as nonvascular mortality, statistical adjustment for conventional cardiovascular risk factors "resulted in considerable weakening of associations," note the scientists of the Cambridge-based Emerging Risk Factors Collaboration (ERFC), who report their findings online December 21, 2009 in the Lancet. In an editorial accompanying the paper [2], Drs S Matthijs Boekholdt and John JP Kastelein (Academic Medical Center, Amsterdam, the Netherlands) say the UK authors "are to be commended for this impressive data set." Although the findings "add weight to the evidence of noncausality" for a role of CRP in the development of cardiovascular disease, "the debate can be resolved only by randomized trials with agents that specifically target CRP, and such compounds are currently under development," say the Dutch doctors. Commenting on the new meta-analysis for heartwire, Dr Paul Ridker (Brigham and Women's Hospital, Boston, MA), a long-time advocate of CRP and the lead investigator of the JUPITER trial, said: "Whether or not CRP is 'causal' for heart disease is neither the crucial issue at hand nor relevant for public health. What is crucial is getting international agreement that CRP identifies higher-risk individuals who would not otherwise qualify for a life-saving therapy, and then showing that such individuals clearly benefit from treatment. The new meta-analysis demonstrates the former, and JUPITER demonstrates the latter." "

C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. The Lancet, Early Online Publication, 22 December 2009 doi:10.1016/S0140-6736(09)61717-7 Interpretation CRP concentration has continuous associations with the risk of coronary heart disease, ischaemic stroke, vascular mortality, and death from several cancers and lung disease that are each of broadly similar size. The relevance of CRP to such a range of disorders is unclear. Associations with ischaemic vascular disease depend considerably on conventional risk factors and other markers of inflammation.

Long-term consumption of a carbohydrate-restricted diet does not induce deleterious metabolic effects. Grieb P, K?apcin'ska B, Smol E, Pilis T, Pilis W, Sadowska-Krepa E, Sobczak A, Bartoszewicz Z, Nauman J, Stan'czak K, Langfort J. Nutr Res. 2008 Dec;28(12):825-33. PMID: 19083495 doi:10.1016/j.nutres.2008.09.011 These results indicate that long-term (>1 year) compliance with a low-CHO high-fat "optimal diet" does not induce deleterious metabolic effects and does not increase the risk for cardiovascular disease, as evidenced by maintenance of adequate glycemic control and relatively low values for conventional cardiovascular risk factors.

Incremental effects of eicosapentaenoic acid on cardiovascular events in statin-treated patients with coronary artery disease. Matsuzaki M, Yokoyama M, Saito Y, Origasa H, Ishikawa Y, Oikawa S, Sasaki J, Hishida H, Itakura H, Kita T, Kitabatake A, Nakaya N, Sakata T, Shimada K, Shirato K, Matsuzawa Y; JELIS Investigators. Circ J. 2009 Jul;73(7):1283-90. Epub 2009 May 8. PMID: 19423946 Conclusions: EPA is effective for secondary prevention of CAD, especially in individuals with prior MI, and should be added to conventional treatment.

One-year comparison of a high-monounsaturated fat diet with a high-carbohydrate diet in type 2 diabetes. Brehm BJ, Lattin BL, Summer SS, Boback JA, Gilchrist GM, Jandacek RJ, D'Alessio DA. Diabetes Care. 2009 Feb;32(2):215-20. Epub 2008 Oct 28. PMID: 18957534 doi: 10.2337/dc08-0687 CONCLUSIONS-In individuals with type 2 diabetes, high-MUFA diets are an alternative to conventional lower-fat, high-CHO diets with comparable beneficial effects on body weight, body composition, cardiovascular risk factors, and glycemic control.

"This site provides information on herbal medicine (as distinct from herbal medicines) sometimes also called phytotherapy. Herbological.com is maintained by Jonathan Treasure, a medical herbalist with professional qualifications in both conventional medical sciences and herbal medicine from the UK, now located in Southern Oregon, USA. (See bio and consulting pages for further details) "

The summer season each year brings wafting memories of a juicy and luscious fruit called litchi. The origins of Litchi lie in southern China where as a crop it has been cultivated uninterruptedly for close to 2500 years. Its geographical propagation has been rather slow, which is due to the short life-span of its seed and the peculiar soil and climatic requirements associated with the plant.A classical instance of this is India which is the second largest producer just behind China, but litchi farming is chronologically speaking, very recent having been introduced only sometime in the middle of the 1700's. Together China and India between themselves produce more than 90% of the world's Litchi, leaving the rest of the world far behind. In the backdrop of all this it is interesting to know the various cultivars and varieties which dot the world of Litchi farming. Most or all of them have their genesis probably in China but have been suitably bred and modified to thrive in countries of their adoption.

The terms 'cultivar' and 'variety' have often been used interchangeably but this convention often seems to ignore the obvious differences which exist between the two. A 'cultivar' is bred with the help of vegetative propagation, which could include cutting, grafting,budding and tissue culture and is a product of human effort and ingenuity. A 'variety' on the other hand is a natural phenomenon and is bred through seedlings. A 'variety' will always produce clones of the parent plant, but in a cultivar,there may be slight variation in a progeny compared to the parent particularly in the case of hybrids. The Litchi cultivars in India number about 40 out of which around 12 or 13 are commercially cultivated.The same cultivar or variety may be known by different names in various parts of the country. In China there are about 200 known cultivars although only 20 or so are in commercial farming, which means the genetic repository is much more widespread compar